Abstract
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have